Skip to the content
  • Suomeksi
  • About Us
    • > Our role
    • > BoD and management
    • > Sustainability
  • Pharma Sector
    • > Feasibilities and inquiries
    • > Research archive
    • > References for post-licensure studies
  • Newsfeed
  • Contacts
  • Suomeksi

Category: Press releases

  • In category Press releasesPosted on 10.04.2024

    Finnish research expertise utilizing national register data produces internationally unique information

    The results of pragmatic FinFluHD influenza trial conducted in Finland have been published in a peer-reviewed “Influenza and Other Respiratory Viruses” journal. The trial evaluated the effectiveness of the high-dose flu vaccine in people over 65 years of age. The goal of the FinFluHD trial was to find out whether a high-dose vaccine containing four […]

  • About Us
    • Our role
    • BoD and management
    • Sustainability
  • Pharma Sector
    • Feasibilities and inquiries
    • Research archive
    • References for post-licensure studies
  • Newsfeed
  • Contacts

FVR - Finnish Vaccine Research
Peltokatu 26, 33100 Tampere, Finland
info@fvr.fi Business ID FI32566594

  • About cookies

© Copyrights 2022 FVR – Finnish Vaccine Research